Barbara Costantini
Overview
Explore the profile of Barbara Costantini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santullo F, Vargiu V, Rosati A, Costantini B, Gallotta V, Lodoli C, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 40021580
No abstract available.
2.
Santullo F, Vargiu V, Rosati A, Costantini B, Gallotta V, Lodoli C, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2665-2666.
PMID: 39849253
No abstract available.
3.
Santullo F, Vargiu V, Rosati A, Costantini B, Gallotta V, Lodoli C, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2620-2628.
PMID: 39755893
Background: Anastomotic leakage (AL) is a major complication in colorectal surgery, particularly following rectal cancer surgery, necessitating effective prevention strategies. The increasing frequency of colorectal resections and anastomoses during cytoreductive...
4.
Fagotti A, Costantini B, Fanfani F, Giannarelli D, De Iaco P, Chiantera V, et al.
J Clin Oncol
. 2024 Nov;
43(7):852-860.
PMID: 39571127
Purpose: To investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-free survival (PFS), as opposed to SCS...
5.
Restaino S, Schierano S, Arcieri M, Costantini B, Poli A, Pregnolato S, et al.
Front Surg
. 2024 Sep;
11:1434730.
PMID: 39323910
This narrative review describes the state of the art in the management of anastomotic leakage in ovarian cancer. Multiple surgical procedures, including bowel resection, are often required to achieve "optimal"...
6.
Bizzarri N, Pedone Anchora L, Teodorico E, Certelli C, Galati G, Carbone V, et al.
Eur J Surg Oncol
. 2024 Aug;
50(12):108645.
PMID: 39214031
Objective: Peritoneal involvement may be overlooked in patients with locally advanced cervical cancer (LACC). This may lead to underestimation of prognosis and to undertreatment limited to locoregional disease locations. However,...
7.
Ghirardi V, Trozzi R, Scanu F, Giannarelli D, Santullo F, Costantini B, et al.
Ann Surg Oncol
. 2024 Feb;
31(5):3350-3360.
PMID: 38411761
Background: Randomized data on patients with FIGO stage III ovarian cancer receiving ≤ 3 cycles of neoadjuvant chemotherapy (NACT) showed that hyperthermic intraperitoneal chemotherapy (HIPEC) after interval debulking surgery (IDS)...
8.
Gioe A, Monterossi G, Gueli Alletti S, Panico G, Campagna G, Costantini B, et al.
Int J Gynaecol Obstet
. 2024 Feb;
166(1):258-265.
PMID: 38299809
Objective: To evaluate the safety and feasibility of the new surgical robot HUGO robotic assisted surgery (RAS) in a series of gynecologic surgical procedures. Methods: Between March and October 2022,...
9.
Tortorella L, Cappuccio S, Giannarelli D, Nero C, Marchetti C, Gallotta V, et al.
Gynecol Oncol
. 2024 Jan;
182:57-62.
PMID: 38262239
Objective: In the era of target therapy and personalized medicine, BRCA mutational status has a major influence on survival in ovarian cancer patients. Our aim is to verify if the...
10.
Cappuccio S, Marchetti C, Altintas D, Oliva R, Russo S, Costantini B, et al.
Int J Gynecol Cancer
. 2023 Dec;
34(2):293-299.
PMID: 38135438
Objective: Retrospective series have shown secondary cytoreductive surgery improves oncological outcomes in recurrent low-grade serous ovarian cancer. We aim to compare surgical procedures and complications between patients with low-grade and...